GlassScriptPhysician profile
Bojan Pavlovic
NPI 1760673206
$4,053.71
in general payments reported to CMS, 2019-2025
46 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.97 · 2021: $282 · 2022: $652 · 2023: $806 · 2024: $1,076 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,106.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $436.78 | 2021-2025 | Relistor |
| Abbvie INC. | $307.54 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $275.79 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $274.67 | 2021-2024 | Ztlido |
| Nevro Corp. | $246.20 | 2023-2024 | Senza |
| Globus Medical, INC. | $236.35 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $222.47 | 2022-2025 | Xtampza |
| Protega Pharmaceutials INC | $218.65 | 2025 | Roxybond |
| Eisai INC. | $217.82 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $162.99 | 2023-2025 | Hyqvia |
| Medtronic, INC. | $126.99 | 2024-2025 | Intellis Adaptivestim, Stealthstation S8 Platform, Inceptiv |
| Biohaven Pharmaceutical Holding Company LTD. | $113.87 | 2022 | |
| Abbott Laboratories | $94.83 | 2022-2023 | Proclaim |
| Pfizer INC. | $93.46 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $63.45 | 2023-2024 | Nuedexta, Rexulti |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bojan Pavlovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.